approval · primary record
BRENTUXIMAB VEDOTIN
FDA · BLA · 2025-02-11
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-02-11 |
| Brand | ADCETRIS |
| Sponsor | SEATTLE GENETICS |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:37.567Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BRENTUXIMAB VEDOTIN:2025-02-11
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.